CLINICAL_TRIALS
trial_result
· 2018-01-03
Clinical Trial Update: XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC [Phase 3]
Summary
A Phase 3 trial comparing XELOX/mFOLFOX plus Vitamin D3 versus XELOX/mFOLFOX alone as first-line chemotherapy in metastatic colorectal cancer is ongoing with st…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Vitamin D3 | Phase 3 | Status: UNKNOWN